Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June ... of a specific metabolic pathway in infected cells can diminish latent ...

Venetoclax is under clinical development by AbbVie and currently in Phase I for Primary Mediastinal B-Cell Lymphoma.

Venetoclax is under clinical development by AbbVie and currently in Phase II for Relapsed Acute Myeloid Leukemia.

Kisspeptin-10 (KP-10) peptide, a derivative of the larger kisspeptin protein family, has garnered interest in recent years due to its molecular structure and potential to influence various ...

Peptides, as versatile biological molecules, have garnered significant attention in scientific research due to their ...

Alon Kahana, MD, PhD, discusses the role of interleukin-6 in thyroid eye disease and the potential of tourmaline Bio's IL-6 ...

The research team from the Natural Product Drug Development Center at the Korea Institute of Science and Technology has developed a new therapeutic agent for dry Age-related macular ...

Can Heart Heal Itself?A research team co-led by a physician-scientist at the University of Arizona College of Medicine – ...

Retatrutide, a synthetic peptide with unique properties, has recently gained attention for its multifunctional roles and the ...

Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

Cellular research indicates that neuropilin-1 plays a crucial role in pain signaling, presenting a potential pathway for ...

This study reveals how SARS-CoV-2 infection significantly alters human milk composition, while COVID-19 vaccination causes ...